Aktie KPL6 KWALITY PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kwality Pharmaceuticals Limited

Aktien

KPL6

INE552U01010

KPL6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:19:01 26.04.2024 		% 5 Tage % 1. Jan.
507 INR +1.36% Intraday Chart für Kwality Pharmaceuticals Limited +13.03% +26.81%
06.02. Kwality Pharmaceuticals Limited meldet Ergebnis für die neun Monate bis zum 31. Dezember 2023 CI
2023 Kwality Pharmaceuticals Limited meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Kwality Pharmaceuticals Limited Provides Update on Resumption of Operations At Amritsar
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Kwality Pharmaceuticals Discloses Completion of EU GMP Inspection at Himachal Pradesh, India Unit
Kwality Pharmaceuticals Limited Receives ANVISA Approval for Cephalosporin Plant (Unit -II)
Kwality Pharmaceuticals Limited Announces Change in Directorate
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Bulgarian Drug Agency to Conduct Audit on Kwality Pharmaceuticals' Plant in Himachal Pradesh, India
Kwality Pharmaceuticals to Bring Oncology Injection in Brazil
Kwality Pharmaceuticals to Market Oncology Injection in Brazil
Kwality Pharmaceuticals Received ANVISA Approval For Oncology Injection
Kwality Pharmaceuticals Receives ANVISA Approval For Oncology Injection
Kwality Pharmaceuticals Limited Announces the Resignation of Sachin Seth as Non- Executive and Non Independent Director
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
ICRA Assigns BBB Rating on Kwality Pharmaceuticals' Bank Loans; Outlook Stable
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Kwality Pharmaceuticals Gets In-Principle Approval to Migrate to BSE Main Board
Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. KPL6 Aktie
  4. Nachrichten Kwality Pharmaceuticals Limited
  5. Andere Sprachen